| 1. | Abdominal Neoplasms (14 studies) |
| 2. | Adenocarcinoma (969 studies) |
| 3. | Adenocarcinoma, Clear Cell (26 studies) |
| 4. | Adenocarcinoma, Follicular (17 studies) |
| 5. | Adenocarcinoma, Mucinous (3 studies) |
| 6. | Adenoma (51 studies) |
| 7. | Adenoma, Islet Cell (6 studies) |
| 8. | Adenoma, Oxyphilic (1 study) |
| 9. | Adenoma, Pleomorphic (1 study) |
| 10. | Adrenal Cortex Neoplasms (5 studies) |
| 11. | Adrenal Gland Neoplasms (7 studies) |
| 12. | Anus Neoplasms (11 studies) |
| 13. | Appendiceal Neoplasms (1 study) |
| 14. | Astrocytoma (262 studies) |
| 15. | Basal Cell Nevus Syndrome (2 studies) |
| 16. | Bile Duct Neoplasms (17 studies) |
| 17. | Biliary Tract Neoplasms (19 studies) |
| 18. | Bladder Neoplasms (88 studies) |
| 19. | Blast Crisis (4 studies) |
| 20. | Bone Cysts (2 studies) |
| 21. | Bone Neoplasms (48 studies) |
| 22. | Brain Neoplasms (317 studies) |
| 23. | Brain Stem Neoplasms (2 studies) |
| 24. | Breast Neoplasms (625 studies) |
| 25. | Breast Neoplasms, Male (44 studies) |
| 26. | Brenner Tumor (18 studies) |
| 27. | Bronchial Neoplasms (304 studies) |
| 28. | Burkitt Lymphoma (271 studies) |
| 29. | Carcinoid Tumor (48 studies) |
| 30. | Carcinoma (1214 studies) |
| 31. | Carcinoma in Situ (23 studies) |
| 32. | Carcinoma, Acinar Cell (1 study) |
| 33. | Carcinoma, Adenoid Cystic (47 studies) |
| 34. | Carcinoma, Adrenal Cortical (19 studies) |
| 35. | Carcinoma, Basal Cell (53 studies) |
| 36. | Carcinoma, Bronchogenic (1 study) |
| 37. | Carcinoma, Ductal (9 studies) |
| 38. | Carcinoma, Ductal, Breast (12 studies) |
| 39. | Carcinoma, Embryonal (24 studies) |
| 40. | Carcinoma, Endometrioid (30 studies) |
| 41. | Carcinoma, Hepatocellular (120 studies) |
| 42. | Carcinoma, Intraductal, Noninfiltrating (17 studies) |
| 43. | Carcinoma, Islet Cell (25 studies) |
| 44. | Carcinoma, Large Cell (1 study) |
| 45. | Carcinoma, Lobular (9 studies) |
| 46. | Carcinoma, Medullary (2 studies) |
| 47. | Carcinoma, Merkel Cell (16 studies) |
| 48. | Carcinoma, Mucoepidermoid (45 studies) |
| 49. | Carcinoma, Neuroendocrine (139 studies) |
| 50. | Carcinoma, Non-Small-Cell Lung (430 studies) |
| 51. | Carcinoma, Papillary (14 studies) |
| 52. | Carcinoma, Renal Cell (180 studies) |
| 53. | Carcinoma, Small Cell (158 studies) |
| 54. | Carcinoma, Squamous Cell (278 studies) |
| 55. | Carcinoma, Transitional Cell (72 studies) |
| 56. | Carcinoma, Verrucous (40 studies) |
| 57. | Carcinosarcoma (15 studies) |
| 58. | Cecal Neoplasms (1 study) |
| 59. | Cell Transformation, Neoplastic (1 study) |
| 60. | Central Nervous System Neoplasms (239 studies) |
| 61. | Cervical Intraepithelial Neoplasia (1 study) |
| 62. | Cervix Dysplasia (2 studies) |
| 63. | Cervix Neoplasms (89 studies) |
| 64. | Cholangiocarcinoma (16 studies) |
| 65. | Chondrosarcoma (23 studies) |
| 66. | Chordoma (9 studies) |
| 67. | Choriocarcinoma (24 studies) |
| 68. | Choroid Neoplasms (1 study) |
| 69. | Choroid Plexus Neoplasms (39 studies) |
| 70. | Coin Lesion, Pulmonary (1 study) |
| 71. | Colonic Neoplasms (255 studies) |
| 72. | Colorectal Neoplasms (349 studies) |
| 73. | Colorectal Neoplasms, Hereditary Nonpolyposis (2 studies) |
| 74. | Cranial Nerve Neoplasms (9 studies) |
| 75. | Craniopharyngioma (33 studies) |
| 76. | Cystadenocarcinoma (28 studies) |
| 77. | Cystadenocarcinoma, Mucinous (26 studies) |
| 78. | Cystadenocarcinoma, Serous (28 studies) |
| 79. | Cysts (15 studies) |
| 80. | Dermatofibroma (38 studies) |
| 81. | Dermoid Cyst (14 studies) |
| 82. | Digestive System Neoplasms (771 studies) |
| 83. | Duodenal Neoplasms (20 studies) |
| 84. | Dysgerminoma (1 study) |
| 85. | Endocrine Gland Neoplasms (362 studies) |
| 86. | Endocrine Neoplasm (362 studies) |
| 87. | Endodermal Sinus Tumor (25 studies) |
| 88. | Endometrial Neoplasms (34 studies) |
| 89. | Endometrial Stromal Tumors (3 studies) |
| 90. | Ependymoma (81 studies) |
| 91. | Epstein-Barr Virus Infections (30 studies) |
| 92. | Esophageal Neoplasms (117 studies) |
| 93. | Esthesioneuroblastoma, Olfactory (37 studies) |
| 94. | Eye Neoplasms (51 studies) |
| 95. | Fallopian Tube Neoplasms (4 studies) |
| 96. | Fibroadenoma (1 study) |
| 97. | Fibroma (4 studies) |
| 98. | Fibromatosis, Aggressive (14 studies) |
| 99. | Fibrosarcoma (24 studies) |
| 100. | Gallbladder Neoplasms (16 studies) |
| 101. | Ganglion Cysts (96 studies) |
| 102. | Gastrinoma (24 studies) |
| 103. | Gastrointestinal Neoplasms (549 studies) |
| 104. | Genital Neoplasms, Female (449 studies) |
| 105. | Genital Neoplasms, Male (399 studies) |
| 106. | Germinoma (14 studies) |
| 107. | Gestational Trophoblastic Neoplasms (37 studies) |
| 108. | Glioblastoma (200 studies) |
| 109. | Glioma (328 studies) |
| 110. | Glioma, Subependymal (31 studies) |
| 111. | Gliosarcoma (65 studies) |
| 112. | Glucagonoma (18 studies) |
| 113. | Hamartoma (4 studies) |
| 114. | Hamartoma Syndrome, Multiple (1 study) |
| 115. | Head and Neck Neoplasms (296 studies) |
| 116. | Hemangioblastoma (4 studies) |
| 117. | Hemangioma (5 studies) |
| 118. | Hemangioma, Capillary (2 studies) |
| 119. | Hemangiopericytoma (30 studies) |
| 120. | Hemangiosarcoma (17 studies) |
| 121. | Hematologic Neoplasms (50 studies) |
| 122. | Hepatoblastoma (7 studies) |
| 123. | Histiocytic Disorders, Malignant (46 studies) |
| 124. | Histiocytoma, Fibrous (38 studies) |
| 125. | Hodgkin Disease (269 studies) |
| 126. | Hutchinson's Melanotic Freckle (1 study) |
| 127. | Hydatidiform Mole (3 studies) |
| 128. | Hypopharyngeal Neoplasms (49 studies) |
| 129. | Hypothalamic Neoplasms (6 studies) |
| 130. | Ileal Neoplasms (20 studies) |
| 131. | Infratentorial Neoplasms (1 study) |
| 132. | Insulinoma (21 studies) |
| 133. | Intestinal Neoplasms (367 studies) |
| 134. | Jaw Cysts (2 studies) |
| 135. | Jejunal Neoplasms (20 studies) |
| 136. | Kidney Neoplasms (250 studies) |
| 137. | Kidney, Cystic (2 studies) |
| 138. | Lambert-Eaton Myasthenic Syndrome (1 study) |
| 139. | Laryngeal Neoplasms (52 studies) |
| 140. | Leiomyoma (6 studies) |
| 141. | Leiomyomatosis (2 studies) |
| 142. | Leiomyosarcoma (52 studies) |
| 143. | Leukemia (775 studies) |
| 144. | Leukemia, B-Cell (32 studies) |
| 145. | Leukemia, B-Cell, Chronic (241 studies) |
| 146. | Leukemia, Basophilic, Acute (14 studies) |
| 147. | Leukemia, Eosinophilic, Acute (14 studies) |
| 148. | Leukemia, Erythroblastic, Acute (60 studies) |
| 149. | Leukemia, Hairy Cell (78 studies) |
| 150. | Leukemia, Lymphocytic (441 studies) |
| 151. | Leukemia, Lymphocytic, Acute (317 studies) |
| 152. | Leukemia, Lymphocytic, Acute, L1 (162 studies) |
| 153. | Leukemia, Lymphocytic, Acute, L2 (1 study) |
| 154. | Leukemia, Lymphocytic, Chronic (241 studies) |
| 155. | Leukemia, Megakaryocytic, Acute (60 studies) |
| 156. | Leukemia, Mixed-Cell (1 study) |
| 157. | Leukemia, Monocytic, Acute (52 studies) |
| 158. | Leukemia, Myelocytic, Acute (369 studies) |
| 159. | Leukemia, Myeloid (483 studies) |
| 160. | Leukemia, Myeloid, Aggressive-Phase (138 studies) |
| 161. | Leukemia, Myeloid, Chronic (323 studies) |
| 162. | Leukemia, Myeloid, Chronic-Phase (164 studies) |
| 163. | Leukemia, Myeloid, Philadelphia-Positive (2 studies) |
| 164. | Leukemia, Myelomonocytic, Acute (62 studies) |
| 165. | Leukemia, Myelomonocytic, Chronic (139 studies) |
| 166. | Leukemia, Neutrophilic, Chronic (30 studies) |
| 167. | Leukemia, Nonlymphocytic, Acute (38 studies) |
| 168. | Leukemia, Prolymphocytic (61 studies) |
| 169. | Leukemia, Promyelocytic, Acute (45 studies) |
| 170. | Leukemia, T-Cell (123 studies) |
| 171. | Leukemia, T-Cell, Acute (17 studies) |
| 172. | Leukemia, T-Cell, Chronic (50 studies) |
| 173. | Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated (118 studies) |
| 174. | Leukoplakia (3 studies) |
| 175. | Leukoplakia, Hairy (1 study) |
| 176. | Leukoplakia, Oral (2 studies) |
| 177. | Li-Fraumeni Syndrome (1 study) |
| 178. | Lip Neoplasms (38 studies) |
| 179. | Liposarcoma (23 studies) |
| 180. | Liver Neoplasms (137 studies) |
| 181. | Lung Neoplasms (384 studies) |
| 182. | Lymphangioma (1 study) |
| 183. | Lymphangiomyoma (2 studies) |
| 184. | Lymphangiomyomatosis (4 studies) |
| 185. | Lymphatic Vessel Tumors (3 studies) |
| 186. | Lymphoma (906 studies) |
| 187. | Lymphoma, AIDS-Related (64 studies) |
| 188. | Lymphoma, B-Cell (178 studies) |
| 189. | Lymphoma, Diffuse (124 studies) |
| 190. | Lymphoma, Follicular (216 studies) |
| 191. | Lymphoma, High-Grade (82 studies) |
| 192. | Lymphoma, Intermediate-Grade (90 studies) |
| 193. | Lymphoma, Large-Cell (411 studies) |
| 194. | Lymphoma, Large-Cell, Diffuse (348 studies) |
| 195. | Lymphoma, Large-Cell, Follicular (312 studies) |
| 196. | Lymphoma, Large-Cell, Immunoblastic (295 studies) |
| 197. | Lymphoma, Large-Cell, Ki-1 (117 studies) |
| 198. | Lymphoma, Low-Grade (60 studies) |
| 199. | Lymphoma, Lymphoblastic (284 studies) |
| 200. | Lymphoma, Mantle-Cell (292 studies) |
| 201. | Lymphoma, Mixed-Cell (325 studies) |
| 202. | Lymphoma, Mixed-Cell, Diffuse (293 studies) |
| 203. | Lymphoma, Mixed-Cell, Follicular (310 studies) |
| 204. | Lymphoma, Mucosa-Associated Lymphoid Tissue (98 studies) |
| 205. | Lymphoma, Non-Hodgkin (589 studies) |
| 206. | Lymphoma, Small Cleaved-Cell, Diffuse (286 studies) |
| 207. | Lymphoma, Small Cleaved-Cell, Follicular (310 studies) |
| 208. | Lymphoma, Small Lymphocytic (192 studies) |
| 209. | Lymphoma, Small Noncleaved-Cell (128 studies) |
| 210. | Lymphoma, Small-Cell (192 studies) |
| 211. | Lymphoma, T-Cell (261 studies) |
| 212. | Lymphoma, T-Cell, Cutaneous (179 studies) |
| 213. | Lymphoma, T-Cell, Peripheral (5 studies) |
| 214. | Lymphoma, Undifferentiated (93 studies) |
| 215. | Lymphomatoid Granulomatosis (13 studies) |
| 216. | Lymphomatoid Papulosis (1 study) |
| 217. | Macular Edema, Cystoid (5 studies) |
| 218. | Malignant Carcinoid Syndrome (10 studies) |
| 219. | Malignant Fibrous Histiocytoma (38 studies) |
| 220. | Mastocytosis (8 studies) |
| 221. | Mastocytosis, Systemic (2 studies) |
| 222. | Mediastinal Neoplasms (2 studies) |
| 223. | Medullary Thyroid Carcinoma (19 studies) |
| 224. | Medulloblastoma (82 studies) |
| 225. | Melanoma (272 studies) |
| 226. | Meningeal Neoplasms (23 studies) |
| 227. | Meningioma (46 studies) |
| 228. | Mesenchymoma (12 studies) |
| 229. | Mesothelioma (55 studies) |
| 230. | Mixed Tumor, Malignant (1 study) |
| 231. | Mouth Neoplasms (100 studies) |
| 232. | Multiple Endocrine Neoplasia (2 studies) |
| 233. | Multiple Endocrine Neoplasia Type 1 (1 study) |
| 234. | Multiple Myeloma (310 studies) |
| 235. | Muscle Neoplasms (21 studies) |
| 236. | Mycosis Fungoides (118 studies) |
| 237. | Myelitis, Transverse (1 study) |
| 238. | Myosarcoma (108 studies) |
| 239. | Nasopharyngeal Carcinoma (116 studies) |
| 240. | Nasopharyngeal Neoplasms (30 studies) |
| 241. | Neoplasm Metastasis (743 studies) |
| 242. | Neoplasm Recurrence, Local (1 study) |
| 243. | Neoplasms (5694 studies) |
| 244. | Neoplasms by Histologic Type (2982 studies) |
| 245. | Neoplasms by Site (3169 studies) |
| 246. | Neoplasms, Adipose Tissue (5 studies) |
| 247. | Neoplasms, Basal Cell (18 studies) |
| 248. | Neoplasms, Bone Tissue (59 studies) |
| 249. | Neoplasms, Complex and Mixed (19 studies) |
| 250. | Neoplasms, Connective and Soft Tissue (285 studies) |
| 251. | Neoplasms, Connective Tissue (92 studies) |
| 252. | Neoplasms, Ductal, Lobular, and Medullary (11 studies) |
| 253. | Neoplasms, Experimental (30 studies) |
| 254. | Neoplasms, Fibroepithelial (11 studies) |
| 255. | Neoplasms, Fibrous Tissue (19 studies) |
| 256. | Neoplasms, Germ Cell and Embryonal (773 studies) |
| 257. | Neoplasms, Glandular and Epithelial (1207 studies) |
| 258. | Neoplasms, Hormone-Dependent (1 study) |
| 259. | Neoplasms, Mesothelial (35 studies) |
| 260. | Neoplasms, Multiple Primary (1 study) |
| 261. | Neoplasms, Muscle Tissue (53 studies) |
| 262. | Neoplasms, Nerve Tissue (749 studies) |
| 263. | Neoplasms, Neuroepithelial (356 studies) |
| 264. | Neoplasms, Squamous Cell (25 studies) |
| 265. | Neoplasms, Unknown Primary (16 studies) |
| 266. | Neoplasms, Vascular Tissue (84 studies) |
| 267. | Neoplastic Endocrine-Like Syndromes (7 studies) |
| 268. | Neoplastic Processes (334 studies) |
| 269. | Neoplastic Syndromes, Hereditary (33 studies) |
| 270. | Nephroblastoma (49 studies) |
| 271. | Nerve Sheath Tumors (9 studies) |
| 272. | Nervous System Neoplasms (247 studies) |
| 273. | Neurilemmoma (3 studies) |
| 274. | Neuroblastoma (127 studies) |
| 275. | Neuroectodermal Tumors (760 studies) |
| 276. | Neuroectodermal Tumors, Primitive (133 studies) |
| 277. | Neuroectodermal Tumors, Primitive, Peripheral (82 studies) |
| 278. | Neuroendocrine Tumors (385 studies) |
| 279. | Neurofibroma (9 studies) |
| 280. | Neurofibroma, Plexiform (4 studies) |
| 281. | Neurofibromatoses (10 studies) |
| 282. | Neurofibromatosis 1 (6 studies) |
| 283. | Neurofibromatosis 2 (5 studies) |
| 284. | Neurofibrosarcoma (20 studies) |
| 285. | Neuroma (3 studies) |
| 286. | Neuroma, Acoustic (3 studies) |
| 287. | Nevi and Melanomas (243 studies) |
| 288. | Nevus (248 studies) |
| 289. | Nevus, Pigmented (245 studies) |
| 290. | Nose Neoplasms (26 studies) |
| 291. | Ocular Melanoma (3 studies) |
| 292. | Odontogenic Cysts (2 studies) |
| 293. | Oligodendroglioma (126 studies) |
| 294. | Optic Nerve Glioma (6 studies) |
| 295. | Optic Nerve Neoplasms (7 studies) |
| 296. | Oropharyngeal Neoplasms (94 studies) |
| 297. | Osteosarcoma (89 studies) |
| 298. | Otorhinolaryngologic Neoplasms (124 studies) |
| 299. | Ovarian Carcinosarcoma (3 studies) |
| 300. | Ovarian Cysts (6 studies) |
| 301. | Ovarian Neoplasms (278 studies) |
| 302. | Paget's Disease, Mammary (4 studies) |
| 303. | Pancreatic Neoplasms (164 studies) |
| 304. | Papilloma (40 studies) |
| 305. | Paraganglioma (5 studies) |
| 306. | Paranasal Sinus Neoplasms (19 studies) |
| 307. | Paraneoplastic Syndromes (9 studies) |
| 308. | Paraneoplastic Syndromes, Nervous System (2 studies) |
| 309. | Parathyroid Neoplasms (3 studies) |
| 310. | Pelvic Neoplasms (2 studies) |
| 311. | Penile Neoplasms (3 studies) |
| 312. | Peripheral Nervous System Neoplasms (11 studies) |
| 313. | Peritoneal Neoplasms (14 studies) |
| 314. | Peutz-Jeghers Syndrome (1 study) |
| 315. | Pharyngeal Neoplasms (113 studies) |
| 316. | Pheochromocytoma (20 studies) |
| 317. | Phyllodes Tumor (1 study) |
| 318. | Pinealoma (25 studies) |
| 319. | Pituitary Neoplasms (18 studies) |
| 320. | Plasmacytoma (300 studies) |
| 321. | Pleural Effusion, Malignant (17 studies) |
| 322. | Pleural Neoplasms (7 studies) |
| 323. | Polycystic Kidney Diseases (2 studies) |
| 324. | Polycystic Kidney, Autosomal Dominant (1 study) |
| 325. | Polycystic Kidney, Autosomal Recessive (1 study) |
| 326. | Polycystic Ovary Syndrome (6 studies) |
| 327. | Precancerous Conditions (12 studies) |
| 328. | Pregnancy Complications, Neoplastic (2 studies) |
| 329. | Preleukemia (414 studies) |
| 330. | Prostatic Intraepithelial Neoplasia (1 study) |
| 331. | Prostatic Neoplasms (355 studies) |
| 332. | Proteus Syndrome (1 study) |
| 333. | Pseudomyxoma Peritonei (10 studies) |
| 334. | Rectal Neoplasms (241 studies) |
| 335. | Respiratory Tract Neoplasms (453 studies) |
| 336. | Reticuloendotheliosis (63 studies) |
| 337. | Retinal Neoplasms (8 studies) |
| 338. | Retinoblastoma (24 studies) |
| 339. | Rhabdoid Tumor (12 studies) |
| 340. | Rhabdomyosarcoma (81 studies) |
| 341. | Rhabdomyosarcoma, Alveolar (3 studies) |
| 342. | Rhabdomyosarcoma, Embryonal (21 studies) |
| 343. | Salivary Gland Neoplasms (25 studies) |
| 344. | Sarcoma (301 studies) |
| 345. | Sarcoma, Alveolar Soft Part (10 studies) |
| 346. | Sarcoma, Clear Cell (8 studies) |
| 347. | Sarcoma, Endometrial Stromal (10 studies) |
| 348. | Sarcoma, Ewing's (73 studies) |
| 349. | Sarcoma, Kaposi (88 studies) |
| 350. | Sarcoma, Synovial (23 studies) |
| 351. | Secondary Acute Myeloid Leukemia (139 studies) |
| 352. | Seminoma (26 studies) |
| 353. | Sezary Syndrome (114 studies) |
| 354. | Sigmoid Neoplasms (2 studies) |
| 355. | Skin Neoplasms (178 studies) |
| 356. | Skull Neoplasms (26 studies) |
| 357. | Soft Tissue Neoplasms (23 studies) |
| 358. | Somatostatinoma (19 studies) |
| 359. | Spinal Cord Neoplasms (10 studies) |
| 360. | Spinal Neoplasms (1 study) |
| 361. | Stomach Neoplasms (91 studies) |
| 362. | Sturge-Weber Syndrome (21 studies) |
| 363. | Supratentorial Neoplasms (6 studies) |
| 364. | Teratoma (35 studies) |
| 365. | Testicular Neoplasms (42 studies) |
| 366. | Thoracic Neoplasms (404 studies) |
| 367. | Thymoma (15 studies) |
| 368. | Thymus Neoplasms (3 studies) |
| 369. | Thyroid Neoplasms (17 studies) |
| 370. | Thyroid Nodule (1 study) |
| 371. | Trophoblastic Neoplasms (37 studies) |
| 372. | Trophoblastic Tumor, Placental Site (3 studies) |
| 373. | Tuberous Sclerosis (5 studies) |
| 374. | Tumor Virus Infections (38 studies) |
| 375. | Ureteral Neoplasms (35 studies) |
| 376. | Urethral Neoplasms (28 studies) |
| 377. | Urogenital Neoplasms (1071 studies) |
| 378. | Urologic Neoplasms (278 studies) |
| 379. | Urticaria Pigmentosa (2 studies) |
| 380. | Uterine Neoplasms (159 studies) |
| 381. | Uveal Neoplasms (1 study) |
| 382. | Vaginal Neoplasms (6 studies) |
| 383. | Vascular Neoplasms (84 studies) |
| 384. | Vipoma (1 study) |
| 385. | Vulvar Neoplasms (7 studies) |
| 386. | Warts (6 studies) |
| 387. | Xeroderma Pigmentosum (3 studies) |
| 388. | Zollinger-Ellison Syndrome (7 studies) |
